What Experience are you Designing for your cell therapy? Nuvera’s second infographic in a series of five focuses on highlighting how the experiences of patients, referring physicians, treatment centers, and the cells themselves relate to each other.
Mapping the details associated with the end-to-end treatment experience with ACTs is essential for a manufacturer to zero in on issues that are not only the most critical but also those they are most qualified to solve for (vs. trying to solve for everything). Our ACT Treatment Experience infographic will help shed some light on important considerations as you undertake this effort.
The ACT Treatment Experience infographic provides a broad overview of some of the areas where a biopharma manufacturer can influence the various elemental journeys with examples of inflection points requiring intervention or support in some form from your organization. Stay tuned for our next infographic which revolves around the functions and stakeholders involved across the ACT experience.
Download infographic The Complexities of the ACT-Treatment Experience
Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.
Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.
Jump to a slide with the slide dots.
The nuvera series touching upon several commercialization issues surrounding Autologous Cell Therapies (ACTs).
Read moreLearn key insights for seamless execution when Managing ACT stakeholders, from internal teams to third-party partners.
Read moreHow seamless is your cell therapy order process? Discover key strategies for managing Autologous Cell Therapy (ACT) orders efficiently.
Read moreFrom order management to patient services, a strong ACT tech ecosystem is essential. Discover key strategies to enable seamless integration.
Read more